Breast Cancer Clinical Trial
Official title:
Metabolic Genotypes and Oncogenic Damage in Breast Cancer
RATIONALE: Studying samples of urine and blood from patients with cancer in the laboratory
may help doctors learn more about changes that occur in DNA and identify biomarkers related
to cancer.
PURPOSE: This study is looking at urine and blood samples in women with newly diagnosed
breast cancer.
OBJECTIVES:
- To determine the association between the genotype for 4 metabolic enzymes (e.g., CYP1A1,
GSTM, GSTT, and GSTP) in women with newly diagnosed breast cancer that play key roles in
the metabolism of environmental human carcinogens and the risk of breast cancer
development.
OUTLINE: Urine and blood samples are collected for DNA, mutation, and polymorphism analysis.
The biological samples may be stored and used for future research.
Patients complete a Baseline Questionnaire to collect basic risk/exposure information,
including demographic factors (e.g., age, weight, height, and body mass index),
menstrual/reproductive history, medical history, medication use, smoking history, alcohol
consumption, exposure to chest x-ray, and family history of breast cancer in first-degree
relatives. Patients also complete a Second Hand Smoke Questionnaire to collect information on
cigarette smoking history and second hand smoke exposure and a Food Frequency Questionnaire
to collect information on the frequency of use of specific fruits and vegetables (e.g.,
cruciferous vegetables) and to estimate usual dietary intake of 33 nutrients during the past
year (e.g., total fat, saturated fat, oleic fat, linoleic fat, carbohydrates, protein,
vitamins [e.g., A, B1, B2, niacin, B6, folate, C, and E], minerals [e.g., calcium, magnesium,
iron, and zinc], electrolytes [e.g., sodium and potassium], and dietary fiber). Patients'
medical charts are also reviewed to collect information on age, gender, ethnic background,
medical history, and medical care.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |